Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Pfizer

Did Pfizer make a 'scandalous' admission to the European Parliament about its COVID-19 vaccine?

Despite a claim that has gone viral, Pfizer never said that pre-market trials of its COVID-19 vaccine tested for its effect on transmission of the virus.

ABC News

4 Income Stocks You Could Buy and Hold Forever

As the central banks worldwide are determined to battle sky-high inflation with big rate hikes, top economists warn of a global recession on the way. While volatility is rife in the stock market, reliable dividend-paying stocks Pfizer (PFE), McKesson (MCK), Nutrien (NTR), and Genie Energy (GNE) might be ideal investments…

StockNews.com

At-risk populations in the dark about Covid treatments

Years of sometimes confusing messaging on Covid has left half the people eligible for antiviral treatment unaware of it

Newsroom.co.nz

From analysis to the latest developments in health,
read the most diverse news in one place.

US clears Novavax COVID booster dose

The Food and Drug Administration has authorized a booster dose of the COVID-19 vaccine made by Novavax

The Independent UK

Covid winter boosters, new vaccines and why side effects may be different

Everybody over 50 is invited for a winter coronavirus jab but not everybody will get the new dual/bivalent vaccines that target multiple strains

Chronicle Live

Ask the Doctors: Omicron variant COVID-19 boosters are now recommended for all

More than 90% of new COVID9 cases nationwide are being caused by infection with the omicron variant. So it’s a relief that there’s a tool to fight that.

Chicago Sun-Times

2 Stocks to Buy Now That Won’t Put Your Portfolio at Risk

With inflation showing no sign of cooling down, the Fed is expected to continue with its rate hikes, raising the chances of a recession. Healthcare stocks have historically provided a cushion in such hazy times. Hence, fundamentally robust stocks Johnson & Johnson (JNJ) and Pfizer (PFE) might be safe additions…

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Why IBD Stock Of The Day Sarepta Just Snagged A Price Target Hike Over Pfizer

IBD Stock Of The Day Sarepta will lead the gene therapy market in treating a form of muscular dystrophy, an analyst said Monday.

Investors Business Daily

Looking At Pfizer's Recent Whale Trades

Someone with a lot of money to spend has taken a bearish stance on Pfizer (NYSE:PFE). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

Cancer vaccine being hailed by leading Covid scientists

The husband-and-wife duo who founded BioNTech has made a ‘breakthrough’ in the development of a cancer vaccine

Evening Standard

Cancer vaccine could be available by 2030 thanks to scientists behind Covid jab

The professors said that there was 'a number of breakthroughs' during the Covid vaccine development.

Daily Record

'Cancer vaccine' could be available in next 10 years as scientists behind vital jab raise hopes

German couple Professors Ugur Sahin and Ozlem Tureci said they are hesitant to say they can find a cure for cancer, but that they have had “breakthroughs” they will keep working on.

Irish Mirror

Vaccines to treat cancer possible by 2030, say BioNTech founders

Uğur Şahin and Özlem Türeci say mRNA Covid vaccine technology could be repurposed to help destroy cancer cells

The Guardian - UK

What vaccine can you get, based on your age? These are the recommended COVID-19 vaccines for each age group

More than 14.2 million Australians over the age of 16 have now received three or more doses. So which are the best vaccines for each age group?

ABC News

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Cancer vaccine could be available by 2030, say scientists behind Covid jab

German couple Professors Ugur Sahin and Ozlem Tureci said they have had ‘breakthroughs’ they will keep working on.

The Denver Post

Colorado’s omicron booster shot campaign picking up after slow start

DENVER — Uptake of new boosters targeting variants of omicron is slowly increasing, in a change from the days when getting a COVID-19 vaccine appointment felt like a competitive sport.

Tribune News Service

Pfizer says booster lifts antibodies for omicron variants

Pfizer Inc. and its German vaccine partner said their booster tailored to the latest omicron variants raised more antibodies against the dominant strains of COVID-19 when compared with the original shot designed to fight the form of the virus.

Asharq Al-Awsat

Pfizer, BioNTech Find Updated COVID Booster Protects against Omicron in Trial

Pfizer and its German partner BioNTech said their COVID-19 vaccine booster, adapted for the BA.4 and the BA.5 subvariants of Omicron, generated a strong immune response and was well-tolerated in testing on humans. With the results, which the companies described as consistent with preclinical data, the partners are following up…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Moderna Rallies On Merck Collaboration: Can Drugmaker Replace COVID Vaccine Revenue?

In late 2020, when the world was searching for a vaccine or cure for COVID-19, the price action in Moderna Inc (NASDAQ: MRNA) was discussed frequently on Benzinga's PreMarket Prep show.

Bangkok Post

Ministry kicks off Pfizer jabs for toddlers

The Ministry of Public Health kicked off the first round of Covid-19 vaccinations for the youngest demographic in the country on Wednesday.

WEKU

How this Brazilian doc got nearly every person in her city to take a COVID vaccine

Dr. Gabriela Kucharski's city of Toledo had virtually no vaccines. And it's a bastion of support for Brazil's vaccine skeptic president. Here's why that didn't matter.

The Guardian - US

FDA authorizes Covid vaccine boosters for children five and above

Moderna vaccine has been approved for children six years and older, while children as young as five can get Pfizer

Tribune News Service

FDA authorizes COVID omicron boosters for kids 5 and up

COVID-19 vaccine makers Pfizer Inc. and Moderna Inc. received U.S. regulatory clearances for their omicron-targeted boosters for children as young as 5.

WEKU

Omicron boosters for kids 5-12 are cleared by the CDC

Tweaked boosters rolled out for Americans 12 and older last month, modified to target today's most common and contagious variant. The latest move may expand protection before an expected winter wave.

The Independent UK

FDA clears updated COVID boosters for kids as young as 5

The U.S. is about to offer updated COVID-19 booster shots to kids as young as 5

1 … 30 31 32 33

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

UK Health Security Agency

485 stories

Food and Drug Administration

British Heart Foundation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.